Our writers provide unique, surprising and engaging content for our visitors about the cancer survivors, doctors and treatments that shape the lives of those living with mesothelioma.
An estimated 3,000 people in the United States are diagnosed annually with malignant mesothelioma cancer. When they need assistance, more than half of…
In October 2020, the U.S. Food and Drug Administration approved a combination of the immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy) as a new…
